Please try another search
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Chih-Hui Lin | - | 2005 | Chairman, GM, Managerial Officer & President |
Xiang-Lang Liu | 40 | 2003 | Independent Director |
Xiu-Mei Lin | 40 | 2019 | Independent Director |
You-Peng Zhang | 43 | 2019 | Representative Director |
Li-Wen Huang | 51 | 2009 | Representative Director |
San-Chien Tu | - | 2023 | Additional Independent Director |
Huilan Qiu | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review